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Abstract While signiﬁcant morbidity due to respiratory
syncytial virus (RSV) infection in the paediatric popu-
lation has been well acknowledged, little is known about
the burden of inﬂuenza in primarily healthy children in
Europe. In our institution, a University Children’s
Hospital in Switzerland, medical staﬀ were encouraged
to take nasopharyngeal specimens for multiplex poly-
merase chain reaction assays for inﬂuenza A and B, RSV
and several other pathogens from patients hospitalised
with respiratory symptoms. We took advantage of this
strategy and performed a retrospective study to compare
speciﬁc characteristics of inﬂuenza virus infections with
those of RSV during two consecutive winter seasons.
Overall, 126 patients were positive for RSV and 60
patients were positive for inﬂuenza (type A: 45; type
B: 15). The median age of children with RSV, inﬂuenza
A, and inﬂuenza B infection was 4 months; 2 years and 4
months; and 6 years and 2 months, respectively
(P<0.001). Fever and cough predominated in children
with inﬂuenza infection whereas cough, rhinorrhoea,
feeding diﬃculties and dyspnoea were the major symp-
toms in children with RSV infection. Of patients with
inﬂuenza, 41% suﬀered from lower respiratory tract
infection compared to 91% of those with RSV infection
(P<0.001). Of 60 patients hospitalised with inﬂuenza,
12 (20%) experienced febrile convulsions. None of the
patients with inﬂuenza had been immunised in the
respective winter season, although 27% of them had at
least one underlying medical condition that would have
counted as an indication for immunisation in Switzer-
land. Conclusion: Inﬂuenza virus infections, like
respiratory syncytial virus infections, are a major cause
of hospitalisation in children with respiratory illness
during the winter season. Since it is impossible to make
an aetiological diagnosis on clinical grounds, it is
important to apply speciﬁc diagnostic tools in children
hospitalised with respiratory illness in order to better
characterise the relative burden of disease caused by the
respective agents.
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Introduction
Inﬂuenza causes signiﬁcant morbidity and mortality in
elderly people [22] and in chronically ill patients at any
age [6, 10, 18]. The burden of inﬂuenza in primarily
healthy children and adolescents is less clear [6, 10, 18],
although it has long been recognised that acute viral
respiratory tract infections are a common reason for
hospitalisation in children [17, 22]. Among these,
respiratory syncytial virus (RSV) is considered to be
most important as it causes yearly outbreaks of lower
respiratory tract infections (LRTIs), such as bronchio-
litis and pneumonia, primarily in young infants [2, 11,
12, 18]. Recently, several investigations have drawn
attention to the role of inﬂuenza in hospitalised children
in the United States [12, 17, 18] but only limited data are
available on the clinical characteristics of inﬂuenza
infection in children and adolescents in Europe [4, 15,
20, 23, 24, 25]. This may at least be partly explained by
the lack of widely available, sensitive diagnostic tools for
inﬂuenza virus infection and the fact that circulation of
inﬂuenza viruses and RSV frequently overlaps in winter,
making it diﬃcult to separate these two agents as a cause
of respiratory infection [6, 18, 20].
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The aim of this study was to assess the clinical
characteristics of inﬂuenza virus infection in comparison
with RSV in immunocompetent hospitalised children
and adolescents. We chose a 2-year period to account
for the biannual pattern of RSV outbreaks in Switzer-
land [8].
Subjects and methods
Subjects
Our hospital provides general and specialised services
for the paediatric population in the northwest of Swit-
zerland. During the study period, an average of 55,735
children lived in the two cantons of the Basel area
(according to population statistics assessed in December
2001 and December 2002). Until 2000, we used a rapid
antigen test (RAT) for diagnosis of RSV from naso-
pharyngeal specimens (NPS). Starting in 2001, NPS for
multiplex PCR (see below) was collected from patients
hospitalised with respiratory symptoms during the cold
season (October to April). Continuous and/or additional
use of the antigen test for RSV was left to the treating
physician’s discretion.
Virology
NPS were collected on admission and sent to the virol-
ogy laboratory of our hospital where RAT and/or PCR
tests were performed as ordered by the physician. The
multiplex PCR was designed to amplify cDNA speciﬁc
for RSV, parainﬂuenza virus types 1 and 3, inﬂuenza A
and B, and adenovirus by use of primers as previously
described [7, 9, 13, 16, 19] and has undergone compre-
hensive in-house evaluation. All laboratory personnel
were unaware of any clinical information on the
respective patients. Results were usually available within
24 to 48 h. The RAT for RSV (Abbott Test Pack RSV,
Abbott Diagnostic Division, Cham, Switzerland) was
performed according to the manufacturers’ instructions
and results were available the same day.
Data analyses
Cases were identiﬁed by evaluating patient records and
the virology laboratory’s log books. Immunocompro-
mised patients and those with nosocomial infections
were excluded. Characteristics of patients with any po-
sitive test were extracted from their records.
Statistical analyses
Comparisons of percentages were performed by use of
the chi-squared test and those of mean values by the
Mann-Whitney U-test.
Results
Study population
During the study period, 653 eligible patients were
hospitalised with respiratory illnesses. None of them had
received inﬂuenza immunisations. The following analy-
ses are based on 422 (65%) patients from whom NPS
were obtained. Of these, 154 and 268 were hospitalised
during study years 1 and 2.
The virology ﬁndings are presented in Table 1 and
the seasonal distribution of cases in Fig. 1. In the winter
of 2001/2002, the ﬁrst cases of inﬂuenza and RSV
infections leading to hospitalisation did not occur before
January and the two epidemics overlapped. In contrast,
in the following winter the RSV season started in
October whereas the inﬂuenza epidemic occurred as late
as February. RSV and inﬂuenza virus infections were
similarly frequent in the 2001/2002 season whereas in
2002/2003 RSV predominated over inﬂuenza. Overall,
inﬂuenza virus type A infections were more frequent
than those caused by type B (45 versus 15).
Eight double infections were detected: three patients
tested positive for inﬂuenza A and RSV, two for
adenovirus and RSV, one for Mycoplasma pneumoniae
and RSV, one for parainﬂuenza type 3 and RSV, and
one for inﬂuenza B and adenovirus. Since it is impossible
Table 1 Diagnostic tests and
results in patients hospitalised
with respiratory tract infections
Season and test RSV Inﬂuenza A Inﬂuenza B
Positive
(n)/tested (n);
(% positive)
Positive (n)/tested
(n);(% positive)
Positive (n)/tested
(n);(% positive)
2001/2002
PCR 23/110 (21%) 24/112 (21%) 3/112 (3%)
RAT 22/86 (26%) Not applicable Not applicable
Any 35/150 (23%) 24/112 (21%) 3/112 (3%)
2002/2003
PCR 73/242 (30%) 21/226 (9%) 12/226 (5%)
RAT 61/155 (39%) Not applicable Not applicable
Any 91/267 (34%) 21/226 (9%) 12/226 (5%)
Total (Any) 126/417 (30%) 45/338 (13%) 15/338 (4%)
360
to estimate the contribution of the respective organism
to the patient’s characteristics of illness, these cases were
excluded from the following comparisons.
The median age of patients with RSV infection was 4
months (interquartile range 54 days to 1 year; 56%
male) and that of patients with inﬂuenza A and B virus
infections was 2 years and 4 months (interquartile range
1 year to 3 years and 1 month; 52% male) and 6 years
and 2 months (interquartile range 4 years and 8 months
to 9 years and 6 months; 71% male), respectively.
Among patients with RSV, inﬂuenza A and B virus
infections, 97%, 88% and 50%, respectively, were <6
years of age (P<0.001 for RSV versus inﬂuenza). Of 56
patients hospitalised with inﬂuenza infection only, 44
lived in the two cantons of the Basel area. Overall, the
yearly population-based hospitalisation rate for inﬂu-
enza per 100,000 children (0–18 years) in Basel was 39.5
and that for children <6 years of age was 141.
Median duration of hospitalisation in patients with
RSV, inﬂuenzaAandB infectionwas 5 days (interquartile
range 3–8 days), 4 days (interquartile range 3–6 days) and
3 days (interquartile range 2–4 days) and total numbers of
hospital days were 718, 94 and 42 days, respectively
(P<0.001 for RSV versus inﬂuenza) compared to a total
of 1,222 days in patients with negative tests.
Clinical characteristics
Table 2 shows the major clinical diagnoses at the time of
admittance and signs, symptoms and complications of
patients by causative viral infection. A clinical diagnosis
of LRTI was established in 41% of patients with inﬂu-
enza virus infection compared to 91% of those with
RSV infection (P<0.001). Two patients with inﬂuenza B
virus infection suﬀered from myositis which led to
hospitalisation. No deaths occurred. Of 119 patients
with RSV infections, 10 (8%) compared to 2 (4%) of 56
patients with inﬂuenza (P=0.2) required intensive care
treatment during the course of their illness. Nine of
those patients were infants (all with RSV infection).
Interestingly, 11 (20%) patients with inﬂuenza compared
to two (2%) with RSV (P<0.001) experienced febrile
convulsions as a complication of their illness and this
was the primary reason for hospitalisation in all of them.
Less than 30% of patients had underlying conditions
(Table 3).
Laboratory ﬁndings
WBCs and CRP levels were determined in most patients.
Leukocytosis was uncommon with a trend towards a
more frequent occurrence in patients with RSV than
with inﬂuenza (20% versus 9% >15,000/ll; P=0.06).
CRP levels were not or only slightly increased in the
great majority of patients irrespective of viral aetiology.
Discussion
An intensiﬁed laboratory surveillance for inﬂuenza and
RSV infections enabled us to characterise the impact of
hospitalised inﬂuenza and RSV infections in immuno-
competent patients. There were more RSV infections in
the second year of our study. This conﬁrms the known
2-year periodicity of RSV epidemics [8, 14]. In contrast,
the dynamics of inﬂuenza epidemics are less predictable
and onset as well as magnitude may vary in year to year
comparisons [15, 23, 25].
Inﬂuenza infections contributed signiﬁcantly to
hospitalisations of children with respiratory symptoms in
this investigation. Excluding patients with more than one
infectious agent, mean hospitalisation rates were (per
Fig. 1 Monthly hospitalisation
rates for RSV and inﬂuenza
A and B virus infections
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100,000 and year) 39.5 and 141 for children <6 years of
age and all children, respectively. These rates are in the
range of a similar study performed in Germany, a
country with comparable population characteristics [23].
It should be noted, however, that these rates probably are
an underestimation of the true rates, because diagnostic
tests had not been applied in all our patients.
High, unexplained fever and febrile convulsions,
frequently associated with abrupt onset of high fever,
were the major reasons for hospitalisation of those
children. Similarly, febrile convulsions had occurred in
16% of children hospitalised with inﬂuenza in a Finnish
study [20]. Most of our patients with inﬂuenza had
symptoms of upper respiratory tract infections and
establishing a diagnosis of inﬂuenza was helpful for their
medical management. Accordingly, median duration of
hospitalisation was short.
In comparison, children with RSV infections had a
higher rate of lower respiratory tract symptoms and
longer hospital stays, mainly because oxygen supple-
mentation was required. The age distribution of patients
with RSV infections (mainly infants) was markedly dif-
ferent from that of patients with inﬂuenza, most of whom
were pre-school (inﬂuenza A) or school age (inﬂuenza B)
children. A possible explanation for this diﬀerence may
be that passively acquired maternal antibodies do
provide some protection against inﬂuenza [21] but
apparently not against RSV [5]. This is in accordance
with previous ﬁndings from European studies [23, 25],
whereas observations in the United States found highest
rates for inﬂuenza hospitalisation for children in the ﬁrst
2 years of life [17, 18]. We do not have a ready
explanation for this geographic discrepancy.
Most of our patients with inﬂuenza were primarily
healthy children. Although this ﬁnding is not new [20,
22], it indicates that the overall impact of the current
immunisation strategy, which aims at patients with
pre-existing chronic diseases, is limited. Moreover, the
signiﬁcant number of inﬂuenza patients with underlying
diseases indicates that compliance with this strategy is
suboptimal. More eﬀorts are needed to improve this. If
the goal was to prevent serious manifestations of inﬂu-
enza in all children, a general immunisation programme
would be necessary. This strategy has recently been
recommended by the ‘‘US Advisory Committee on
Table 2 Comparative clinical
ﬁndings in 175 patients
hospitalised with RSV,
inﬂuenza A or inﬂuenza B virus
infection
aOne patient with RSV infec-
tion presented only with fever
and feeding diﬃculties
RSV (n=119) a Inﬂuenza A
(n=42)
Inﬂuenza B
(n=14)
P
Positive (%) Positive (%) Positive (%)
Major clinical
diagnoses
Upper respiratory
tract illness
10 (8) 24 (57) 7 (50) <0.001
Croup 0 (0) 2 (5) 1 (7) <0.05
Bronchitis 21 (18) 3 (7) 3 (21) 0.22
Bronchiolitis/obstructive
bronchitis
65 (55) 4 (10) 0 (0) <0.001
Pneumonia 22 (18) 9 (21) 1 (7) 0.9
Myositis 0 (0) 0 (0) 2 (14) <0.05
Signs, symptoms and
complications
Cough 98 (82) 32 (76) 8 (57) 0.09
Rhinorrhoea 81 (68) 19 (45) 6 (43) <0.005
Pharyngitis 58 (49) 17 (41) 7 (50) 0.47
Fever (‡38C) 68 (57) 38 (91) 12 (86) <0.001
High fever (‡39C) 34 (29) 30 (71) 7 (50) <0.001
Dyspnoea 67 (56) 5 (12) 0 (0) <0.001
Otitis media 29 (24) 11 (26) 1 (7) 0.66
Feeding diﬃculties/loss
of appetite
79 (66) 21 (50) 4 (29) <0.01
Vomiting 45 (38) 22 (52) 5 (36) 0.19
Diarrhoea 14 (12) 11 (26) 2 (14) 0.051
Febrile convulsions 2 (2) 9 (21) 2 (14) <0.001
Treatment
Oxygen administration 69 (58) 7 (17) 0 (0) <0.001
Intensive care 10 (8) 2 (5) 0 (0) 0.24
Antibiotics 33 (28) 12 (29) 5 (33) 0.72
Table 3 Comorbidity in patients with RSV and inﬂuenza A and B
virus infections
Underlying
conditions
Virus
RSV
(n=119)
Inﬂuenza
type A
(n=42)
Inﬂuenza
type B
(n=14)
Positive (%) Positive (%) Positive (%)
Prematurity 17 (14) 5 (12) 1 (7)
Chronic lung disease 5 (4) 1 (2) 1 (7)
Cardiovascular disease 4 (3) 0 (0) 0 (0)
Atopic eczema 3 (3) 2 (5) 1 (7)
CNS abnormalities 3 (3) 1 (2) 1 (7)
Others 3 (3) 3 (7) 0(0)
Anya 33 (28) 11 (26) 4 (29)
aSome patients had more than one underlying condition
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Immunization Practices’’ for healthy 6–23-month-old
children [3]. However, it is doubtful whether such a
recommendation would be acceptable in Europe today.
Our study has some limitations. First, of 653 patients
admitted to the hospital with respiratory symptoms, only
422 received diagnostic tests to detect RSV or inﬂuenza
A/B infection. Therefore, it is likely that further cases
among hospitalised patients remained undiagnosed.
However, we do not believe that this has introduced a
signiﬁcant bias in our observational study since lack of
diagnostic procedures appeared to be associated with
individual physicians and not with the patient’s present-
ing symptoms (data not shown). Further, sensitivity and
speciﬁcity of RAT for RSV have been shown to be
suboptimal [1]. Here, in children showing repeatedly
positive RAT results, sensitivity and speciﬁcity when
compared to RT-PCR was only 66% and 63%, respec-
tively. When only children with positive PCR results were
considered in our investigation, the rate of positive spec-
imens decreased from30%to23%.Second, this studywas
limited to hospitalised patients and therefore does not
allow any conclusions to be drawn concerning the whole
spectrum of inﬂuenza disease.
Our results show, that inﬂuenza A or B, like RSV,
infections are a major cause of hospitalisation in the
paediatric population during winter seasons and inves-
tigations to better characterize the spectrum of serious
complications of inﬂuenza in children are in progress.
Based on such results, current immunisation recom-
mendations—which primarily aim at protection of high
risk patients—should be re-evaluated.
Acknowledgements We are grateful to our colleagues and staﬀ at
the University Children’s Hospital Basel for obtaining patients’
specimens. The assistance of R. Hertel and technicians in the
Microbiology Department of our hospital is greatly acknowledged.
References
1. Abels S, Nadal D, Stroehle A, Bossart W (2001) Reliable
detection of respiratory syncytial virus infection in children for
adequate hospital infection control management. J Clin
Microbiol 39: 3135–3139
2. Anderson LJ, Parker RA, Strikas RL (1990) Association
between respiratory syncytial virus outbreaks and lower respi-
ratory tract deaths of infants and young children. J Infect Dis
161: 640–646
3. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Sin-
gleton JA, Practices ACoI (2003) Prevention and control of
inﬂuenza. Recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR Morb Mortal Wkly
Rep 52: 526
4. Brouard J, Ribet V, Petitjean J, Freymuth F, Duhamel JF
(1992) Infection a` virus inﬂuenza A chez l’enfant. Spectre cli-
nique et comparaison avec l’atteinte par le virus respiratoire
syncytial durant l’hiver 1989–1990. Arch Fr Pediatr 49: 693–
697
5. Bulkow LR, Singleton RJ, Karron RA, Harrison LH, Group
ARS (2002) Risk factors for severe respiratory syncytial virus
infection among Alaska native children. Pediatrics 109: 210–
216
6. Chiu SS, Lau YL, Chan KH, Wong WH, Peiris JS (2002)
Inﬂuenza-related hospitalizations among children in Hong
Kong. N Engl J Med 347: 2097–2103
7. Claas EC, Sprenger MJ, Kleter GE, van Beek R, Quint WG,
Masurel N (1992) Type-speciﬁc identiﬁcation of inﬂuenza
viruses A, B and C by the polymerase chain reaction. J Virol
Methods 39: 1-13
8. Duppenthaler A, Gorgievski-Hrisoho M, Frey U, Aebi C
(2003) Two-year periodicity of respiratory syncytial virus epi-
demics in Switzerland. Infection 31: 75–80
9. Fan J, Henrickson KJ (1996) Rapid diagnosis of human
parainﬂuenza virus type 1 infection by quantitative reverse
transcription-PCR-enzyme hybridization assay. J Clin Micro-
biol 34: 1914–1917
10. Glezen WP (1998) Inﬂuenza viruses. In: Feigin RD, Cherry JD
(eds) Textbook of pediatric infectious diseases. Saunders,
Philadelphia, pp 2024–2041
11. Hall CB (1998) Respiratory syncytial virus. In: Feigin RD,
Cherry JD (eds) Textbook of pediatric infectious disease.
Saunders, Philadelphia, pp 2084–2111
12. Izurieta HS, Thompson WW, Kramarz P, Shay DK, Davis
RL, DeStefano F, Black S, Shineﬁeld H, Fukuda K (2000)
Inﬂuenza and the rates of hospitalization for respiratory
disease among infants and young children. N Engl J Med
342: 232–239
13. Karron RA, O’Brien KL, Froehlich JL, Brown VA (1993)
Molecular epidemiology of a parainﬂuenza type 3 virus out-
break on a pediatric ward. J Infect Dis 167: 1441–1445
14. Lyon JL, Stoddard G, Ferguson D, Caravati M, Kaczmare A,
Thompson G, Hegmann K, Hegmann C (1996) An every other
year cyclic epidemic of infants hospitalized with respiratory
syncytial virus. Pediatrics 97: 152–153
15. Meier CR, Napalkov PN, Wegmu¨ller Y, Jeﬀerson T, Jick H
(2000) Population-based study on incidence, risk factors, clin-
ical complications and drug utilisation associated with inﬂu-
enza in the United Kingdom. Eur J Clin Microbiol Infect Dis
19: 834–842
16. Morris DJ, Cooper RJ, Barr T, Bailey AS (1996) Polymerase
chain reaction for rapid diagnosis of respiratory adenovirus
infection. J Infect 32: 113–117
17. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griﬃn MR
(2000) The eﬀect of inﬂuenza on hospitalizations, outpatient
visits, and courses of antibiotics in children. N Engl J Med 342:
225–231
18. Neuzil KM, Zhu Y, Griﬃn MR, Edwards KM, Thompson JM,
Tollefson SJ, Wright PF (2002) Burden of interpandemic
inﬂuenza in children younger than 5 years: a 25-year prospec-
tive study. J Infect Dis 185: 147–152
19. Paton AW, Paton JC, Lawrence AJ, Goldwater PN, Harris RJ
(1992) Rapid detection of respiratory syncytial virus in naso-
pharyngeal aspirates by reverse transcription and polymerase
chain reaction ampliﬁcation. J Clin Microbiol 30: 901–904
20. Peltola V, Ziegler T, Ruuskanen O (2003) Inﬂuenza A and B
virus infections in children. Clin Infect Dis 36: 299–305
21. Reuman PD, Ayoub EM, Small PA (1987) Eﬀect of passive
maternal antibody on inﬂuenza illness in children: a prospective
study of inﬂuenza A in mother-infant pairs. Pediatr Infect Dis
J 6: 398–403
22. Sugaya N, Mitamura K, Nirasawa M, Takahashi K (2000) The
impact of winter epidemics of inﬂuenza and respiratory syn-
cytial virus on paediatric admissions to an urban general hos-
pital. J Med Virol 60: 102–106
23. Weigl JAI, Puppe W, Schmitt HJ (2002) The incidence of
inﬂuenza-associated hospitalizations in children in Germany.
Epidemiol Infect 129: 525–533
24. Wever-Hess J, Wever AM, Yntema JL (1991) Mortality and
morbidity from respiratory diseases in childhood in The
Netherlands, 1980–1987. Eur Respir J 4: 429–433
25. Winter GF, Hallam NF, Hargreaves FD, Molyneaux PJ, Burns
SM, Inglis JM (1996) Respiratory viruses in a hospitalized
paediatric population in Edinburgh 1985–1994. J Infect 33:
207–211
363
